MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
MTLS stock logo

MTLS

Materialise N.V.

$6.63
0.02
 (0.3%)
Exchange:  NASDAQ
Market Cap:  391.615M
Shares Outstanding:  39.072M
Delayed data
Calculate MTLS Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Technology
Industry:  Software – Application
   
CEO:  Brigitte de Vet-Veithen
Full Time Employees:  488
Address: 
Technologielaan 15
Leuven
3001
BE
Website:  https://www.materialise.com
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/07 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue256,127266,765257,070.245
Gross Profit145,131150,825146,912.514
EBITDA30,09231,23825,792.222
Operating Income5,6199,4324,943.861
Net Income6,72213,4367,413.390

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets396,630396,336420,466.970
Total Liabilities160,037147,844165,092.705
Total Stockholders Equity236,646248,578255,453.230
Total Debt64,39841,28466,147.834
Cash and Cash Equivalents127,573102,304133,861.003

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow20,15731,45622,675.294
Capital Expenditure-11,760-26,377-13,535.825
Free Cash Flow8,3975,0799,139.469
Net Income6,584.21213,4067,413.390
Net Change in Cash-13,294-25,26943,699.051

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)371,021.496Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)388,329.327Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)378,944.566Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)45,610.450Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)47,738.138Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)46,584.449Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)26,453.747Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)27,043.826Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)26,748.787Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)141,219.375Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)147,807.136Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)144,235.079Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)0.450Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)0.460Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)0.450Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)2Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)2Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
288.557M  ?P/S
 (TTM)
: 
1.25
?Net Income
 (TTM)
: 
14.534M  ?P/E
 (TTM)
: 
33.16
?Enterprise Value
 (TTM)
: 
263.469M  ?EV/FCF
 (TTM)
: 
42.88
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.04  ?ROIC
 (TTM)
: 
0.03
?Net Debt
 (TTM)
: 
-63186210  ?Debt/Equity
 (TTM)
: 
0.24
?P/B
 (TTM)
: 
1.31  ?Current Ratio
 (TTM)
: 
2.42

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
27.31Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about MTLS valuation

Is Materialise N.V. (MTLS) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Materialise N.V. (MTLS) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is MTLS a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether MTLS trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is MTLS’s P/E ratio?

You can see MTLS’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for MTLS?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is MTLS a good long-term investment?

Whether MTLS fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

MTLS

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

0.3
MARKETSnap

Trading Metrics:

Open: 6.62   Previous Close: 6.61
Day Low: 6.4   Day High: 6.83
Year Low: 4.78   Year High: 7
Price Avg 50: 5.6   Price Avg 200: 5.6
Volume: 190334   Average Volume: 109319

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript
07-05-2026 18:11
Materialise NV (MTLS) Q1 2026 Earnings Call Transcript
Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026
23-04-2026 01:00
Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026
Materialise NV (MTLS) Q4 2025 Earnings Call Transcript
19-02-2026 17:25
Materialise NV (MTLS) Q4 2025 Earnings Call Transcript

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read